Author

Number of items: 3.
2026
  • Inhibition of levodopa-induced abnormal involuntary movements (AIMs) using a selective α7 nicotinic positive allosteric modulator. (2026) Yasaman Malekizadeh, Kiana Hassankhani, Alice E Kingslake, Lucy E Annett, Mohammed Shoaib and Mahmoud M Iravani
    • 2023
  • Neuroprotective properties of arylpiperazine-sulphonamides in in vitro models of Parkinson's disease. (2023) Alice Kingslake, Vukic Soskic and Mahmoud Iravani
  • Alpha7 nicotinic receptor- mediated reduction of L-DOPA-induced dyskinesia in 6OHDA rat model of Parkinson’s Disease. (2023) Yasaman Malekizadeh, Kiana Hassankhani, Alice Kingslake, Lucy Annett, Mohammed Shoaib and Mahmoud Iravani
    • This list was generated on Sun May 3 02:32:30 2026 BST.